Testing for Stain-induced Myopathy

Mark H. Hyman

doi:10.1016/j.amjmed.2006.05.065

Letter| Volume 120, ISSUE 12, e31, December 01, 2007

Testing for Stain-induced Myopathy

Mark H. Hyman, MD
Mark H. Hyman
Affiliations
Associate Clinical Professor Medicine, UCLA, Los Angeles, Calif
Search for articles by this author

DOI:https://doi.org/10.1016/j.amjmed.2006.05.065

The clinically important article by Antons et al.

¹

Antons K.A.
Williams C.D.
Baker S.K.
et al.

Clinical perspectives of statin-induced rhabdomyolysis.

places great weight on use of the creatinine kinase test in their algorithm (Figure 2). I have been interested in whether there is any alternative testing that might be more clinically reliable.

²

Hyman M.H.

Statin-associated myopathy with normal creatinine kinase levels.

Have the authors any experience with alternative blood testing in light of their described limits in creatinine kinase testing?

To read this article in full you will need to make a payment

Purchase one-time access:

Subscribe:

Already a print subscriber? Claim online access

Already an online subscriber? Sign in

Register: Create an account

Institutional Access: Sign in to ScienceDirect

References

- Antons K.A.
- Williams C.D.
- Baker S.K.
- et al.
Clinical perspectives of statin-induced rhabdomyolysis.
Am J Med. 2006; 119: 400-409
View in Article
- Hyman M.H.
Statin-associated myopathy with normal creatinine kinase levels.
Ann Intern Med. 2003; 138 (1007): 12
View in Article

Article Info

Identification

DOI: https://doi.org/10.1016/j.amjmed.2006.05.065

Copyright

ScienceDirect

Access this article on ScienceDirect

Testing for Stain-induced Myopathy

Purchase one-time access:

Subscribe:

References

Article Info

Identification

Copyright

ScienceDirect

Related Articles